Trademark: 90635513
Word
LIPAC
Status
Pending
Status Code
733
Status Date
Tuesday, February 6, 2024
Serial Number
90635513
Mark Type
4000
Filing Date
Friday, April 9, 2021
Published for Opposition
Tuesday, January 4, 2022

Trademark Owner History
LIPAC ONCOLOGY, INC. - 1st New Owner After Publication
Lipac Oncology LLC - Owner At Publication

Classifications
5 Pharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of various cancers utilizing liposomal drug delivery technology

Trademark Events
Feb 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2024
Sou Extension 4 Granted
Feb 6, 2024
Sou Extension 4 Filed
Feb 6, 2024
Sou Teas Extension Received
Aug 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2023
Sou Extension 3 Granted
Aug 15, 2023
Sou Extension 3 Filed
Aug 15, 2023
Sou Teas Extension Received
Mar 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2023
Sou Extension 2 Granted
Feb 28, 2023
Sou Extension 2 Filed
Feb 28, 2023
Sou Teas Extension Received
Aug 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 24, 2022
Sou Extension 1 Granted
Aug 24, 2022
Sou Extension 1 Filed
Aug 24, 2022
Sou Teas Extension Received
Jun 23, 2022
Automatic Update Of Assignment Of Ownership
Mar 1, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 1, 2022
Teas Change Of Correspondence Received
Mar 1, 2022
Teas Change Of Owner Address Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Dec 1, 2021
Law Office Publication Review Completed
Nov 30, 2021
Assigned To Lie
Nov 30, 2021
Approved For Pub - Principal Register
Nov 29, 2021
Assigned To Examiner
Jul 17, 2021
New Application Office Supplied Data Entered
Apr 13, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24